Sangamo and Pfizer Announce Gene Therapy SB-525 Results in Hemophilia Patients and More
July 8, 2019
0
Sangamo and Pfizer Gene Therapy SB-525 Resulted in a Sustained Increase in Factor VIII Levels in Hemophilia Patients Sangamo Therapeutics (SGMO) and Pfizer (